{
    "title": "Alexion Pharma names former Baxalta chief Ludwig Hantson CEO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4352916/UPDATE-1-Alexion-Pharma-names-former-Baxalta-head-Ludwig-Hantson-CEO.html",
    "date": "2017-03-27",
    "keywords": [
        "alexion",
        "drug",
        "appointment",
        "pipeline",
        "company",
        "baxalta",
        "hantson",
        "raredisease",
        "investor",
        "soliris",
        "growth",
        "chief",
        "month",
        "reporting",
        "earlystage",
        "buildout",
        "baxter",
        "grovermarch",
        "monday",
        "ceo",
        "job",
        "maker",
        "confidence",
        "exit",
        "blood",
        "companys",
        "competition",
        "development",
        "termination",
        "departure",
        "aftermath",
        "investigation",
        "uncertainty",
        "strategy",
        "analyst",
        "christopher",
        "saidhantson",
        "brennanbrennan",
        "december",
        "thenceo",
        "david",
        "hallal",
        "officer",
        "vikas",
        "sinha",
        "probe",
        "revenue",
        "recognition",
        "material",
        "weakness",
        "quartershallal",
        "purchase",
        "biopharma",
        "blockbuster",
        "potential",
        "replacement",
        "paltry",
        "effort",
        "vision",
        "focus",
        "marai",
        "role",
        "president",
        "bioscience",
        "drugsbaxalta",
        "shire",
        "plc",
        "deal",
        "year",
        "inc",
        "brennan",
        "board",
        "chairman",
        "shareholder",
        "grover",
        "bengaluru",
        "editing",
        "anil",
        "dsilva",
        "sai",
        "sachin",
        "ravikumar"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}